Medtronic Plc Stock Net Asset

MDT Stock

USD 84.74 0.63 0.75%

Medtronic PLC fundamentals help investors to digest information that contributes to Medtronic PLC's financial success or failures. It also enables traders to predict the movement of Medtronic Stock. The fundamental analysis module provides a way to measure Medtronic PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medtronic PLC stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Medtronic PLC Company Net Asset Analysis

Medtronic PLC's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis

Current Medtronic PLC Net Asset

89.98 B

Most of Medtronic PLC's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medtronic PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Medtronic Net Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Medtronic PLC is extremely important. It helps to project a fair market value of Medtronic Stock properly, considering its historical fundamentals such as Net Asset. Since Medtronic PLC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medtronic PLC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medtronic PLC's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Long Term Debt	Good Will	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Long Term Investments	Short Long Term Debt	Net Tangible Assets	Deferred Long Term Liab	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Cash And Equivalents	Net Working Capital
Total Assets		0.99	0.97	0.77	0.89	0.99	0.88	0.27	0.86	0.87	0.92	0.93	0.41	-0.98	0.79	0.49	-0.7	-0.86	0.04	0.56	-0.65	-0.53	-0.43	-0.39	0.28
Total Stockholder Equity	0.99		0.94	0.73	0.88	0.96	0.85	0.22	0.82	0.92	0.89	0.94	0.34	-0.99	0.83	0.38	-0.77	-0.88	0.1	0.46	-0.73	-0.62	-0.5	-0.47	0.33
Net Debt	0.97	0.94		0.83	0.89	0.99	0.88	0.3	0.85	0.8	0.92	0.86	0.48	-0.92	0.76	0.63	-0.54	-0.79	0.02	0.67	-0.51	-0.42	-0.34	-0.35	0.14
Retained Earnings	0.77	0.73	0.83		0.77	0.81	0.79	0.04	0.75	0.55	0.83	0.67	0.62	-0.67	0.54	0.67	-0.26	-0.68	-0.1	0.76	-0.15	-0.1	-0.1	-0.12	-0.03
Net Receivables	0.89	0.88	0.89	0.77		0.88	0.91	0.16	0.67	0.79	0.81	0.77	0.53	-0.81	0.75	0.37	-0.57	-0.72	0.05	0.42	-0.52	-0.47	-0.42	-0.42	0.22
Total Liab	0.99	0.96	0.99	0.81	0.88		0.89	0.33	0.89	0.8	0.94	0.91	0.48	-0.94	0.73	0.6	-0.59	-0.8	-0.04	0.67	-0.54	-0.42	-0.32	-0.29	0.22
Total Current Assets	0.88	0.85	0.88	0.79	0.91	0.89		0.27	0.74	0.69	0.85	0.76	0.76	-0.78	0.62	0.49	-0.47	-0.62	-0.06	0.57	-0.4	-0.31	-0.25	-0.22	0.15
Short Term Debt	0.27	0.22	0.3	0.04	0.16	0.33	0.27		0.31	0.06	0.2	0.2	0.13	-0.2	-0.05	0.47	0.04	0.2	-0.23	0.35	-0.15	0.07	0.19	0.27	-0.31
Intangible Assets	0.86	0.82	0.85	0.75	0.67	0.89	0.74	0.31		0.56	0.95	0.89	0.45	-0.83	0.41	0.69	-0.46	-0.71	-0.34	0.81	-0.33	-0.12	0.0	0.04	0.34
Accounts Payable	0.87	0.92	0.8	0.55	0.79	0.8	0.69	0.06	0.56		0.7	0.83	0.14	-0.91	0.95	0.11	-0.88	-0.87	0.41	0.15	-0.85	-0.84	-0.69	-0.74	0.31
Long Term Debt	0.92	0.89	0.92	0.83	0.81	0.94	0.85	0.2	0.95	0.7		0.94	0.54	-0.88	0.6	0.61	-0.56	-0.79	-0.18	0.72	-0.38	-0.26	-0.1	-0.16	0.38
Good Will	0.93	0.94	0.86	0.67	0.77	0.91	0.76	0.2	0.89	0.83	0.94		0.33	-0.95	0.69	0.39	-0.78	-0.85	-0.04	0.5	-0.64	-0.5	-0.26	-0.33	0.49
Short Term Investments	0.41	0.34	0.48	0.62	0.53	0.48	0.76	0.13	0.45	0.14	0.54	0.33		-0.25	0.1	0.52	0.06	-0.13	-0.28	0.58	0.19	0.24	0.26	0.21	-0.08
Common Stock	-0.98	-0.99	-0.92	-0.67	-0.81	-0.94	-0.78	-0.2	-0.83	-0.91	-0.88	-0.95	-0.25		-0.82	-0.38	0.8	0.91	-0.11	-0.46	0.76	0.64	0.51	0.48	-0.36
Property Plant Equipment	0.79	0.83	0.76	0.54	0.75	0.73	0.62	-0.05	0.41	0.95	0.6	0.69	0.1	-0.82		0.08	-0.78	-0.83	0.52	0.09	-0.77	-0.86	-0.75	-0.83	0.19
Current Deferred Revenue	0.49	0.38	0.63	0.67	0.37	0.6	0.49	0.47	0.69	0.11	0.61	0.39	0.52	-0.38	0.08		0.19	-0.21	-0.42	0.95	0.18	0.33	0.34	0.32	-0.28
Long Term Investments	-0.7	-0.77	-0.54	-0.26	-0.57	-0.59	-0.47	0.04	-0.46	-0.88	-0.56	-0.78	0.06	0.8	-0.78	0.19		0.78	-0.36	0.1	0.9	0.86	0.63	0.65	-0.57
Short Long Term Debt	-0.86	-0.88	-0.79	-0.68	-0.72	-0.8	-0.62	0.2	-0.71	-0.87	-0.79	-0.85	-0.13	0.91	-0.83	-0.21	0.78		-0.19	-0.35	0.66	0.65	0.57	0.58	-0.47
Net Tangible Assets	0.04	0.1	0.02	-0.1	0.05	-0.04	-0.06	-0.23	-0.34	0.41	-0.18	-0.04	-0.28	-0.11	0.52	-0.42	-0.36	-0.19		-0.49	-0.47	-0.66	-0.65	-0.78	-0.17
Deferred Long Term Liab	0.56	0.46	0.67	0.76	0.42	0.67	0.57	0.35	0.81	0.15	0.72	0.5	0.58	-0.46	0.09	0.95	0.1	-0.35	-0.49		0.17	0.33	0.32	0.35	-0.11
Long Term Debt Total	-0.65	-0.73	-0.51	-0.15	-0.52	-0.54	-0.4	-0.15	-0.33	-0.85	-0.38	-0.64	0.19	0.76	-0.77	0.18	0.9	0.66	-0.47	0.17		0.92	0.79	0.71	-0.28
Capital Surpluse	-0.53	-0.62	-0.42	-0.1	-0.47	-0.42	-0.31	0.07	-0.12	-0.84	-0.26	-0.5	0.24	0.64	-0.86	0.33	0.86	0.65	-0.66	0.33	0.92		0.87	0.89	-0.25
Net Invested Capital	-0.43	-0.5	-0.34	-0.1	-0.42	-0.32	-0.25	0.19	0.0	-0.69	-0.1	-0.26	0.26	0.51	-0.75	0.34	0.63	0.57	-0.65	0.32	0.79	0.87		0.81	-0.11
Cash And Equivalents	-0.39	-0.47	-0.35	-0.12	-0.42	-0.29	-0.22	0.27	0.04	-0.74	-0.16	-0.33	0.21	0.48	-0.83	0.32	0.65	0.58	-0.78	0.35	0.71	0.89	0.81		-0.14
Net Working Capital	0.28	0.33	0.14	-0.03	0.22	0.22	0.15	-0.31	0.34	0.31	0.38	0.49	-0.08	-0.36	0.19	-0.28	-0.57	-0.47	-0.17	-0.11	-0.28	-0.25	-0.11	-0.14

Click cells to compare fundamentals

Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.

Competition

Predict Medtronic PLC

Medtronic Total Assets

Total Assets

94.48 Billion

At this time, Medtronic PLC's Total Assets are comparatively stable compared to the past year.

Based on the recorded statements, Medtronic PLC has a Net Asset of 89.98 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.

Medtronic Net Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medtronic PLC's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medtronic PLC could also be used in its relative valuation, which is a method of valuing Medtronic PLC by comparing valuation metrics of similar companies.

Medtronic PLC is currently under evaluation in net asset category among its peers.

Medtronic PLC ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Medtronic PLC's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Medtronic PLC's managers, analysts, and investors.

Environmental

Governance

Social

Medtronic PLC Institutional Holders

Institutional Holdings refers to the ownership stake in Medtronic PLC that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Medtronic PLC's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Medtronic PLC's value.

		Shares
Franklin Resources Inc	2024-06-30	19.7 M
Deutsche Bank Ag	2024-06-30	16.7 M
Norges Bank	2024-06-30	15.6 M
Legal & General Group Plc	2024-06-30	11.6 M
Royal Bank Of Canada	2024-06-30	11.4 M
Northern Trust Corp	2024-09-30	11.4 M
Ameriprise Financial Inc	2024-06-30	10.9 M
Amvescap Plc.	2024-06-30	10.8 M
Alliancebernstein L.p.	2024-06-30	10.7 M
Vanguard Group Inc	2024-09-30	123.4 M
Blackrock Inc	2024-06-30	111.9 M

Medtronic Fundamentals

	Return On Equity	0.0795
	Return On Asset	0.0442
	Profit Margin	0.12 %
	Operating Margin	0.18 %
	Current Valuation	128.21 B
	Shares Outstanding	1.28 B
	Shares Owned By Insiders	0.25 %
	Shares Owned By Institutions	85.40 %
	Number Of Shares Shorted	10.18 M
	Price To Earning	20.44 X
	Price To Book	2.22 X
	Price To Sales	3.31 X
	Revenue	32.36 B
	Gross Profit	21.71 B
	EBITDA	9.06 B
	Net Income	3.68 B
	Cash And Equivalents	1.54 B
	Cash Per Share	8.59 X
	Total Debt	26.05 B
	Debt To Equity	0.51 %
	Current Ratio	1.76 X
	Book Value Per Share	38.29 X
	Cash Flow From Operations	6.79 B
	Short Ratio	2.19 X
	Earnings Per Share	3.27 X
	Price To Earnings To Growth	1.56 X
	Target Price	96.29
	Number Of Employees	95 K
	Beta	0.85
	Market Capitalization	107.88 B
	Total Asset	89.98 B
	Retained Earnings	30.4 B
	Working Capital	11.15 B
	Current Asset	23.6 B
	Current Liabilities	7.17 B
	Annual Yield	0.03 %
	Five Year Return	2.18 %
	Net Asset	89.98 B

About Medtronic PLC Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Medtronic PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtronic PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtronic PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Medtronic Stock Analysis

When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC